TTY Biopharm Company Limited
4105
Rank in Stocks
#10257
TTY Biopharm Company Limited, along with its associated entities, specializes... TTY Biopharm Company Limited, along with its associated entities, specializes in the creation and distribution of pharmaceutical and chemical products across Taiwan and global markets. Its operations are structured into several key divisions: Oncology, Intensive Care, Healthcare, Export & CDMO, and an "Other" Business Unit. For anti-cancer and supportive therapies, the company markets a range of oncology medications under prominent brand names such as Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre. Addressing infectious diseases and influenza, TTY Biopharm supplies anti-infection drugs including Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax. Furthermore, the firm offers various healthcare-related pharmaceuticals designed for the digestive system, osteoporosis, and metabolic conditions, marketed under brands like Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin. Beyond pharmaceuticals, the company is also involved in distributing functional foods, conducting international trade (import/export), and engaging in investment ventures. Established in 1960, TTY Biopharm maintains its principal office in Taipei, Taiwan.
Share Price
$2.55
Last synced: 2026-11-13
Market Cap
$724.87M
Change (1 day)
0.28%
Change (1 year)
2.11%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade TTY Biopharm Company Limited (4105)
Category
Healthcare
Dividend history for TTY Biopharm Company Limited (4105)
TTY Biopharm Company Limited (stock symbol: 4105) made a total of 19 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $1.66
Dividend yield (TTM) : 5.35%
The sum of all dividends (adjusted for stock splits) is : $1.66
Dividend yield (TTM) : 5.35%
Dividend payments for TTY Biopharm Company Limited (4105) from 2008 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| 2026 (TTM) | $0.14 | 12.80% |
| 2025 | $0.13 | 15.86% |
| 2024 | $0.11 | -1.84% |
| 2023 | $0.11 | 10.77% |
| 2022 | $0.1 | -30.39% |
| 2021 | $0.14 | 6.58% |
| 2020 | $0.14 | -6.33% |
| 2019 | $0.14 | -2.02% |
| 2018 | $0.15 | 18.98% |
| 2017 | $0.12 | 13.65% |
| 2016 | $0.11 | 35.65% |
| 2015 | $0.0806 | 37.88% |
| 2014 | $0.0585 | 45.40% |
| 2013 | $0.0402 | 479.18% |
| 2012 | $0.0069 | 11.18% |
| 2011 | $0.0062 | -79.91% |
| 2010 | $0.0311 | 84.38% |
| 2009 | $0.0169 | -3.53% |
| 2008 | $0.0175 | 0.00% |
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| 2026 (TTM) | $0.14 | 12.80% |
| 2025 | $0.13 | 15.86% |
| 2024 | $0.11 | -1.84% |
| 2023 | $0.11 | 10.77% |
| 2022 | $0.1 | -30.39% |
| 2021 | $0.14 | 6.58% |
| 2020 | $0.14 | -6.33% |
| 2019 | $0.14 | -2.02% |
| 2018 | $0.15 | 18.98% |
| 2017 | $0.12 | 13.65% |
| 2016 | $0.11 | 35.65% |
| 2015 | $0.0806 | 37.88% |
| 2014 | $0.0585 | 45.40% |
| 2013 | $0.0402 | 479.18% |
| 2012 | $0.0069 | 11.18% |
| 2011 | $0.0062 | -79.91% |
| 2010 | $0.0311 | 84.38% |
| 2009 | $0.0169 | -3.53% |
| 2008 | $0.0175 | 0.00% |
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 13.00% |
DE
|
|
| 26.00% |
DE
|
|
| 55.00% |
JP
|
|
| 2.00% |
CH
|
|
| 62.00% |
IL
|
Questions about TTY Biopharm Company Limited's dividend per share
What is TTY Biopharm Company Limited's dividend per share?
TTY Biopharm Company Limited's dividend per share over the last twelve months is $0.14, as of Mar 2026.
What was TTY Biopharm Company Limited's dividend per share in 2025?
In 2025, TTY Biopharm Company Limited's dividend per share was $0.13, 15.86% more than in 2024 ($0.11).
How has TTY Biopharm Company Limited's dividend per share changed since 2020?
From 2020 to 2025, TTY Biopharm Company Limited's dividend per share went from $0.14 to $0.13, an average decline of 1.34% a year.